Amarin Corp Plc (AMRN)

[Dancing in the dark]

i believe what you heard in the responses during the conference call
was indicative of amarin sr. mgmt having not even considered the
notion that the ANCHOR SPA was somehow jeopardized by the AdCom outcome.

the analyst(s) asking the questions were jumping to conclusions
and asking for factual responses, responses amarin management had no
basis to have prepared.

when you prepare for a debate about risk/benefit of vascepa safety/efficacy
in lowering triglycerides and are instead met with discussion
about cardio protection data not yet resulted, you wonder
WTF is going on, but you cannot convey that wonderment to FDA or
amarin stakeholders in an unrehearsed conference call.